|
127 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3245 News |
|
| «12...4445464748495051525354...6566» |
- ||||||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD), Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial completion: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (clinicaltrials.gov) - Aug 12, 2013
P3, N=2808, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed
- | lansoprazole / Generic mfg., esomeprazole / Generic mfg.
New P4 trial: Eradication Rates of Helicobacter Pylori and Its Affecting Factors (clinicaltrials.gov) - Aug 12, 2013
P4, N=2500, Completed, Sponsor: Seoul National University Bundang Hospital
- Menveo (meningococcal-groups A, C, W-135 and Y oligosaccharide CRM197 conjugate vaccine) / GSK
Enrollment closed: Understanding the Immune Response to Two Different Meningitis Vaccines (clinicaltrials.gov) - Aug 11, 2013
P4, N=15, Active, not recruiting, Sponsor: University of Oxford
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD), PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Enrollment closed, Pneumococcal vaccines: Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines (clinicaltrials.gov) - Aug 11, 2013
P3, N=4, Active, not recruiting, Sponsor: University of Oxford
Recruiting --> Active, not recruiting Not yet recruiting --> Active, not recruiting
- Enrollment change: 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea (clinicaltrials.gov) - Aug 11, 2013
P4, N=287, Completed, Sponsor: Seoul National University Bundang Hospital
Not yet recruiting --> Active, not recruiting N=220 --> 287
- Trial completion: 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea (clinicaltrials.gov) - Aug 11, 2013
P4, N=287, Completed, Sponsor: Seoul National University Bundang Hospital
N=220 --> 287 Recruiting --> Completed
- lansoprazole / Generic mfg., esomeprazole / Generic mfg.
Trial completion: Eradication Rates of Helicobacter Pylori and Its Affecting Factors (clinicaltrials.gov) - Aug 10, 2013
P4, N=2500, Completed, Sponsor: Seoul National University Bundang Hospital
Recruiting --> Completed Not yet recruiting --> Completed
- New P1 trial: Leprosy Skin Test Antigens Phase 1 (clinicaltrials.gov) - Aug 8, 2013
P1, N=10, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- ||||| Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine) / GSK
Trial initiation date: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults (clinicaltrials.gov) - Aug 7, 2013
P3, N=165, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Completed Initiation date: May 2012 --> Jan 2013
- | chlorhexidine gluconate / Generic mfg.
New P4 trial: Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children (clinicaltrials.gov) - Aug 7, 2013
P4, N=1269, Completed, Sponsor: Thammasat University
- | New P4 trial, Surgery: The Effect of Sodium Bicarbonate on Postoperative Renal Function in Infective Endocarditis Patients Undergoing Open Heart Surgery (clinicaltrials.gov) - Aug 7, 2013
P4, N=70, Recruiting, Sponsor: Yonsei University
- Trial initiation date: Safer Sex Program for Young African-American Men (clinicaltrials.gov) - Aug 7, 2013
P2, N=620, Recruiting, Sponsor: University of Kentucky
Initiation date: May 2012 --> Jan 2013 Initiation date: Jun 2012 --> Sep 2012
- Enrollment open: Safer Sex Program for Young African-American Men (clinicaltrials.gov) - Aug 7, 2013
P2, N=620, Recruiting, Sponsor: University of Kentucky
Initiation date: Jun 2012 --> Sep 2012 Not yet recruiting --> Recruiting
- | vancomycin / Generic mfg.
New P2 trial: Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software (clinicaltrials.gov) - Aug 5, 2013
P2, N=270, Recruiting, Sponsor: Children's Hospital Los Angeles
- Trial termination: Study of the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine (clinicaltrials.gov) - Aug 5, 2013
P1, N=48, Terminated, Sponsor: McMaster University
Not yet recruiting --> Recruiting Recruiting --> Terminated; Study was terminated after the low dose cohort had been enrolled
- Enrollment change: ECG Leadwires: Disposable Versus Cleaned, Reusable (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=4056, Completed, Sponsor: The Cleveland Clinic
Recruiting --> Terminated; Study was terminated after the low dose cohort had been enrolled N=1000 --> 4056
- |||||||||| Quinvaxem (diphtheria, Tetanus, whole-cell pertussis- HiB - HepB) / GSK
New P3 trial: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject (clinicaltrials.gov) - Aug 4, 2013
P3, N=400, Active, not recruiting, Sponsor: Crucell Holland BV
- Trial completion: ECG Leadwires: Disposable Versus Cleaned, Reusable (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=4056, Completed, Sponsor: The Cleveland Clinic
N=1000 --> 4056 Recruiting --> Completed
- clindamycin phosphate / Generic mfg.
Trial initiation date: Clindamycin to Reduce Preterm Birth in a Low Resource Setting (clinicaltrials.gov) - Aug 2, 2013
P4, N=1726, Recruiting, Sponsor: Christiana Care Health Services
Recruiting --> Completed Initiation date: Apr 2013 --> Jul 2013
- clindamycin phosphate / Generic mfg.
Enrollment open: Clindamycin to Reduce Preterm Birth in a Low Resource Setting (clinicaltrials.gov) - Aug 2, 2013
P4, N=1726, Recruiting, Sponsor: Christiana Care Health Services
Initiation date: Apr 2013 --> Jul 2013 Not yet recruiting --> Recruiting
- Enrollment open: Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults (clinicaltrials.gov) - Jul 31, 2013
P1, N=30, Recruiting, Sponsor: University of Oxford
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- clarithromycin / Generic mfg.
Enrollment change: Clarithromycin Resistant Tailored Therapy (clinicaltrials.gov) - Jul 30, 2013
P4, N=924, Completed, Sponsor: Jin Il Kim
Not yet recruiting --> Recruiting N=1232 --> 924
- clarithromycin / Generic mfg.
Trial completion: Clarithromycin Resistant Tailored Therapy (clinicaltrials.gov) - Jul 30, 2013
P4, N=924, Completed, Sponsor: Jin Il Kim
N=1232 --> 924 Recruiting --> Completed
- ||| New P3 trial: A Phase 3b, Single-Center, Open-label Study to Assess the Immunogenicity and Safety of Novartis Meningococcal B Recombinant Vaccine When Administered at a 0, 2-Month Schedule in Healthy At-Risk Adults Aged 18 to 65 Years Inclusive. (clinicaltrials.gov) - Jul 28, 2013
P3, N=13, Completed, Sponsor: Novartis Vaccines
- | dabigatran etexilate / Generic mfg., argatroban / Generic mfg., enoxaparin sodium / Generic mfg.
New P2 trial: Direct Thrombin Inhibitors Versus LMWH in Staphylococcus Aureus Bacteraemia (clinicaltrials.gov) - Jul 28, 2013
P2, N=80, Recruiting, Sponsor: Universitaire Ziekenhuizen Leuven
- |||| AERAS-404 / Sanofi
Enrollment open: Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants (clinicaltrials.gov) - Jul 28, 2013
P1/2, N=229, Recruiting, Sponsor: Aeras
Recruiting --> Completed Not yet recruiting --> Recruiting
- capecitabine / Generic mfg.
Trial completion, Metastases: Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC) (clinicaltrials.gov) - Jul 24, 2013
P2, N=100, Completed, Sponsor: Fudan University
Not yet recruiting --> Recruiting Recruiting --> Completed
- levamisole / Generic mfg.
Enrollment change: Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients (clinicaltrials.gov) - Jul 23, 2013
P2, N=40, Completed, Sponsor: Shiraz University of Medical Sciences
Recruiting --> Completed N=33 --> 40
- ||| ciprofloxacin oral / Generic mfg.
Enrollment change: Ciprofloxacin BioThrax Co-Administration Study (clinicaltrials.gov) - Jul 22, 2013
P2, N=154, Completed, Sponsor: Emergent BioSolutions
N=33 --> 40 N=120 --> 154
- || Enrollment change: Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (clinicaltrials.gov) - Jul 21, 2013
P1, N=80, Completed, Sponsor: Rempex Pharmaceuticals
N=120 --> 154 N=48 --> 80
- ||| Trial completion: Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (clinicaltrials.gov) - Jul 21, 2013
P1, N=80, Completed, Sponsor: Rempex Pharmaceuticals
N=48 --> 80 Active, not recruiting --> Completed
- | mupirocin / Generic mfg.
Trial termination: Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA) (clinicaltrials.gov) - Jul 17, 2013
P4, N=99, Terminated, Sponsor: B. Braun Medical SA
Active, not recruiting --> Completed Active, not recruiting --> Terminated; The differences seen between treatments led to recalculation of the sample, unattainable in a reasonable time
- mupirocin / Generic mfg.
Enrollment change: Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA) (clinicaltrials.gov) - Jul 17, 2013
P4, N=99, Terminated, Sponsor: B. Braun Medical SA
Active, not recruiting --> Terminated; The differences seen between treatments led to recalculation of the sample, unattainable in a reasonable time N=310 --> 99
- | albendazole / Generic mfg., azithromycin / Generic mfg.
New P4 trial: AZIVAL2: Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (clinicaltrials.gov) - Jul 17, 2013
P4, N=3680, Not yet recruiting, Sponsor: Emory University
- | Adacel (tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine adsorbed) / Sanofi
Trial completion: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents (clinicaltrials.gov) - Jul 17, 2013
P1/2, N=43, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
N=310 --> 99 Active, not recruiting --> Completed
- ||||||| Adacel (tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine adsorbed) / Sanofi, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
Trial completion: Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea (clinicaltrials.gov) - Jul 17, 2013
P3, N=300, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Adacel (tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine adsorbed) / Sanofi
Trial completion: Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents (clinicaltrials.gov) - Jul 17, 2013
P4, N=423, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Nimenrix (MenACWY-TT) / Pfizer
Trial completion: Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612 (clinicaltrials.gov) - Jul 17, 2013
P3, N=697, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- XOMA 3AB / Resilience
Trial completion: Phase 1 PK Study of XOMA 3AB (clinicaltrials.gov) - Jul 17, 2013
P1, N=24, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Latent Tuberculosis Infection in Bone Marrow Transplant Recipients (clinicaltrials.gov) - Jul 16, 2013
P=N/A, N=409, Completed, Sponsor: Asan Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years (clinicaltrials.gov) - Jul 16, 2013
P1, N=420, Completed, Sponsor: Novartis Vaccines
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Resistance of Helicobacter Pylori to Antibiotics in Children (clinicaltrials.gov) - Jul 15, 2013
P=N/A, N=100, Recruiting, Sponsor: HaEmek Medical Center, Israel
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Mycobutin (rifabutin) / Pfizer, Lupin
Enrollment change: Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam (clinicaltrials.gov) - Jul 15, 2013
P2, N=47, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Not yet recruiting --> Recruiting N=32 --> 47
- Mycobutin (rifabutin) / Pfizer, Lupin
Trial completion: Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam (clinicaltrials.gov) - Jul 15, 2013
P2, N=47, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=32 --> 47 Active, not recruiting --> Completed
- Enrollment change: Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) (clinicaltrials.gov) - Jul 14, 2013
P2, N=650, Active, not recruiting, Sponsor: Aeras
Active, not recruiting --> Completed N=1400 --> 650
- |||| Enrollment open: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (clinicaltrials.gov) - Jul 14, 2013
P2, N=500, Recruiting, Sponsor: JN-International Medical Corporation
N=1400 --> 650 Not yet recruiting --> Recruiting
- ||||| Enrollment change: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India (clinicaltrials.gov) - Jul 14, 2013
P3, N=180, Active, not recruiting, Sponsor: Novartis
Not yet recruiting --> Recruiting N=60 --> 180
- Enrollment closed: Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A (clinicaltrials.gov) - Jul 14, 2013
P1, N=40, Active, not recruiting, Sponsor: University of Oxford
N=60 --> 180 Recruiting --> Active, not recruiting
- ||| Enrollment change: POCone-UBiT-IR300 Pediatric Comparison Study (clinicaltrials.gov) - Jul 12, 2013
P4, N=99, Completed, Sponsor: Otsuka America Pharmaceutical
Recruiting --> Active, not recruiting N=60 --> 99
- |||| Trial completion: POCone-UBiT-IR300 Pediatric Comparison Study (clinicaltrials.gov) - Jul 12, 2013
P4, N=99, Completed, Sponsor: Otsuka America Pharmaceutical
N=60 --> 99 Active, not recruiting --> Completed